Bharat Parenterals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
For the nine months, sales was INR 1,597 million compared to INR 1,640.3 million a year ago. Revenue was INR 1,652.9 million compared to INR 1,711.7 million a year ago. Net income was INR 170.1 million compared to INR 185 million a year ago. Basic earnings per share from continuing operations was INR 29.69 compared to INR 32.29 a year ago. Diluted earnings per share from continuing operations was INR 29.69 compared to INR 32.29 a year ago.